Human Genome Epidemiology Literature Finder
Records 1 - 8 (of 8 Records) |
Query Trace: Recurrence and TMPRSS2[original query] |
---|
Association of TMPRSS2-ERG gene fusion with clinical characteristics and outcomes: results from a population-based study of prostate cancer. BMC cancer 2008 8 (1): 230. FitzGerald Liesel M, Agalliu Ilir, Johnson Karynn, Miller Melinda A, Kwon Erika M, Hurtado-Coll Antonio, Fazli Ladan, Rajput Ashish B, Gleave Martin E, Cox Michael E, Ostrander Elaine A, Stanford Janet L, Huntsman David |
Genomic deletion of MAP3K7 at 6q12-22 is associated with early PSA recurrence in prostate cancer and absence of TMPRSS2:ERG fusions. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2013 Feb . Kluth M, Hesse J, Heinl A, Krohn A, Steurer S, Sirma H, Simon R, Mayer PS, Schumacher U, Grupp K, Izbicki JR, Pantel K, Dikomey E, Korbel JO, Plass C, Sauter G, Schlomm T, Minner S |
Clinical significance of ERG rearrangement subtype and its association with increased p53 expression in Japanese and German prostate cancer. Neoplasma 2015 1 62 (2): 278-87. Nishijima J, Hara T, Ikemoto K, Oga A, Kobayashi K, Kawai Y, Matsumoto H, Nagao K, Sasaki K, Gkoleizakis V, Fichtner J, Matsuyama |
Whole-genome and Transcriptome Sequencing of Prostate Cancer Identify New Genetic Alterations Driving Disease Progression. European urology 2017 Sep . Ren Shancheng, Wei Gong-Hong, Liu Dongbing, Wang Liguo, Hou Yong, Zhu Shida, Peng Lihua, Zhang Qin, Cheng Yanbing, Su Hong, Zhou Xiuqing, Zhang Jibin, Li Fuqiang, Zheng Hancheng, Zhao Zhikun, Yin Changjun, He Zengquan, Gao Xin, Zhau Haiyen E, Chu Chia-Yi, Wu Jason Boyang, Collins Colin, Volik Stanislav V, Bell Robert, Huang Jiaoti, Wu Kui, Xu Danfeng, Ye Dingwei, Yu Yongwei, Zhu Lianhui, Qiao Meng, Lee Hang-Mao, Yang Yuehong, Zhu Yasheng, Shi Xiaolei, Chen Rui, Wang Yang, Xu Weidong, Cheng Yanqiong, Xu Chuanliang, Gao Xu, Zhou Tie, Yang Bo, Hou Jianguo, Liu Li, Zhang Zhensheng, Zhu Yao, Qin Chao, Shao Pengfei, Pang Jun, Chung Leland W K, Xu Jianfeng, Wu Chin-Lee, Zhong Weide, Xu Xun, Li Yingrui, Zhang Xiuqing, Wang Jian, Yang Huanming, Wang Jun, Huang Haojie, Sun Yingh |
Nuclear ELAC2 overexpression is associated with increased hazard for relapse after radical prostatectomy. Oncotarget 2019 Aug 10 (48): 4973-4986. Schroeder Cornelia, Navid-Hill Elham, Meiners Jan, Hube-Magg Claudia, Kluth Martina, Makrypidi-Fraune Georgia, Simon Ronald, Büscheck Franziska, Luebke Andreas M, Goebel Cosima, Lang Dagmar S, Weidemann Sören, Neubauer Emily, Hinsch Andrea, Jacobsen Frank, Lebok Patrick, Michl Uwe, Pehrke Dirk, Huland Hartwig, Graefen Markus, Schlomm Thorsten, Sauter Guido, Höflmayer Dor |
SPOP and FOXA1 mutations are associated with PSA recurrence in ERG wt tumors, and SPOP downregulation with ERG-rearranged prostate cancer. The Prostate 2019 5 79 (10): 1156-1165. Hernández-Llodrà Silvia, Segalés Laura, Safont Ainara, Juanpere Nuria, Lorenzo Marta, Fumadó Lluís, Rodríguez-Vida Alejo, Cecchini Lluís, Bellmunt Joaquim, Lloreta-Trull Jos |
Clinicopathological and molecular characteristics of prostate cancer diagnosed in young men aged up to 45 years. Histopathology 2020 Dec . Baniak Nicholas, Sholl Lynette M, Mata Douglas A, D'Amico Anthony V, Hirsch Michelle S, Acosta Andres |
Determination of ERG(+), EZH2, NKX3.1, and SPINK-1 subtypes to evaluate their association with clonal origin and disease progression in multifocal prostate cancer. Cancer reports (Hoboken, N.J.) 2022 10 e1728. Segura-Moreno Yenifer Yamile, Sanabria-Salas María Carolina, Mesa-López De Mesa Jorge Andrés, Varela-Ramirez Rodolfo, Acosta-Vega Natalia Lizeth, Serrano Martha Luc |
- Page last reviewed:Oct 1, 2023
- Page last updated:Dec 11, 2023
- Content source: